Videos Health Innovators – Jo Brewer, Adaptimmune In this episode of Health Innovators, pharmaphorum founder Paul Tunnah interviews Jo Brewer, senior vice president of allogeneic res
Views & Analysis Deep Dive: Oncology 2021 This has probably been the toughest year for oncology researchers in memory.
Views & Analysis Changing focus to cachexia may be key to improved cancer out... Cachexia could be the next blockbuster area in cancer therapeutics because of its link to survival outcomes. Physician and researcher Dr.
Views & Analysis The next generation of immunotherapy? Innate Pharma targets ... Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer.
Events Partner Content Triple Negative Breast Cancer Drug Development Digital Summi... Fast-track the Discovery & Development of TNBC
News Pfizer deal paves way for approval of ImaginAb's cancer imag... ImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for approval of its tumour imaging agent as a medical device in markets in the US and oth
News Lilly gets back in infectious disease, via three M&A deals Around seven years after exiting the infectious disease category, Eli Lilly is back – thanks to a trio of acquisitions worth more than $3.8bn.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
